s20098 has been researched along with Stroke in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Long, J; Wang, F; Wang, Y | 1 |
| Bogolepova, AN; Chukanova, AS; Chukanova, EI; Gracheva, IIu; Semushkina, EG; Smirnova, MIu | 1 |
| Levin, IaI | 1 |
1 trial(s) available for s20098 and Stroke
| Article | Year |
|---|---|
[The use of valdoxan in the treatment of post-stroke depression].
Topics: Acetamides; Aged; Aged, 80 and over; Antidepressive Agents; Cognition; Depression; Drug Administration Schedule; Emotions; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Stroke | 2011 |
2 other study(ies) available for s20098 and Stroke
| Article | Year |
|---|---|
Agomelatine prevents macrophage infiltration and brain endothelial cell damage in a stroke mouse model.
Topics: Acetamides; Animals; Blood-Brain Barrier; Brain; Cell Hypoxia; Cell Movement; Chemokine CCL2; Claudin-5; Disease Models, Animal; Down-Regulation; Endothelial Cells; Infarction, Middle Cerebral Artery; Macrophages; Mice; Permeability; Stroke; Tight Junction Proteins | 2021 |
[Clinical experience in using agomelatin (valdoxan) in the neurological practice].
Topics: Acetamides; Aged; Benzodiazepines; Depression; Female; Fibromyalgia; Humans; Hypnotics and Sedatives; Male; Middle Aged; Migraine Disorders; Sleep Initiation and Maintenance Disorders; Stroke; Withholding Treatment | 2011 |